We investigated the combined association of rare variants in BRCA2, ATM, NBN, and PALB2 (5) and common variants, evaluated with a multi-ancestry prostate cancer PRS (7), on prostate cancer risk in a study of 3,220 men of African ancestry. This evidence concerns the gene PALB2 and prostate carcinoma.